Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 5
Submit an article Journal homepage
796
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Functional OCT4-specific CD4+ and CD8+ T cells in healthy controls and ovarian cancer patients

Jiabo Di Department of Tumor Immunology; Nijmegen Centre for Molecular Life Sciences; Radboud University Nijmegen Medical Centre; Nijmegen, The Netherlands
,
Leon F.A.G. Massuger Department of Obstetrics and Gynecology; Radboud University Nijmegen Medical Centre; Nijmegen, The Netherlands
,
Tjitske Duiveman-de Boer Department of Tumor Immunology; Nijmegen Centre for Molecular Life Sciences; Radboud University Nijmegen Medical Centre; Nijmegen, The Netherlands
,
Petra L.M. Zusterzeel Department of Obstetrics and Gynecology; Radboud University Nijmegen Medical Centre; Nijmegen, The Netherlands
,
Carl G Figdor Department of Tumor Immunology; Nijmegen Centre for Molecular Life Sciences; Radboud University Nijmegen Medical Centre; Nijmegen, The Netherlands
&
Ruurd Torensma Department of Tumor Immunology; Nijmegen Centre for Molecular Life Sciences; Radboud University Nijmegen Medical Centre; Nijmegen, The NetherlandsCorrespondence[email protected]
Article: e24271 | Received 27 Jan 2013, Accepted 12 Mar 2013, Published online: 01 Apr 2013

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

ShuChen Lin, YingChun Xu, ZhiHua Gan, Kun Han, HaiYan Hu, Yang Yao, MingZhu Huang & DaLiu Min. (2016) Monitoring cancer stem cells: insights into clinical oncology. OncoTargets and Therapy 9, pages 731-740.
Read now

Articles from other publishers (8)

Kai Liang, Xinwei Pan, Yumei Chen & Shaode Huang. (2023) Anti-ovarian cancer actions and pharmacological targets of plumbagin. Naunyn-Schmiedeberg's Archives of Pharmacology 396:6, pages 1205-1210.
Crossref
Jing Ding, Yan Zhang & Yan Che. (2022) Ovarian cancer stem cells: Critical roles in anti-tumor immunity. Frontiers in Genetics 13.
Crossref
Hiroyuki Tsuchiya & Goshi Shiota. (2021) Immune evasion by cancer stem cells. Regenerative Therapy 17, pages 20-33.
Crossref
Christina Wefers, Gerty Schreibelt, Leon F. A. G. Massuger, I. Jolanda M. de Vries & Ruurd Torensma. (2018) Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG. Frontiers in Immunology 9.
Crossref
Jianhua Liu, Lu Wang, Yaoling Wang, Wenjie Zhang & Yilin Cao. (2017) Phenotypic characterization and anticancer capacity of CD8+ cytokine-induced killer cells after antigen-induced expansion. PLOS ONE 12:4, pages e0175704.
Crossref
Christina Wefers, Laurens J. Lambert, Ruurd Torensma & Stanleyson V. Hato. (2015) Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence. Gynecologic Oncology 137:2, pages 335-342.
Crossref
Angela Vasaturo, Martijn Verdoes, Jolanda de Vries, Ruurd Torensma & Carl G. Figdor. (2015) Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment. Immunobiology 220:2, pages 243-248.
Crossref
Jiabo Di, Tjitske Duiveman-de Boer, Petra L. M. Zusterzeel, Carl G. Figdor, Leon F. A. G Massuger & Ruurd Torensma. (2013) The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients. Cellular Oncology 36:5, pages 363-374.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.